title: [Long-term suppressive effect of falecalcitriol on parathyroid hormone secretion in secondary hyperparathyroidism in hemodialysis patients].
abstract: Alfacarcidol and calcitriol are widely used to treat secondary hyperparathyroidism associated with chronic renal failure, but it is often not possible to administer doses high enough to sufficiently inhibit parathyroid hormones because of the risk of hypercalcemia and hyperphosphatemia. We administered falecalcitriol (Hornel) Tablets) to patients with poorly controlled secondary hyperparathyroidism. The usefulness of falecalcitriol was demonstrated by the fact that control of intact-PTH was maintained for up to 24 months without a clear increase in serum Ca x serum inorganic phosphorus (iP), iP, and ALP levels.
authors: Ryoshukai Fujii Shinryosho, Division of Pharmacy.
authors: Yoko
authors: Y
authors: Iwao
authors: Yuki
authors: Y
authors: Yamaguchi
authors: Kumiko
authors: K
authors: Fujii
authors: Yoshikazu
authors: Y
authors: Toba
authors: Masahiro
authors: M
authors: Asada
authors: Naomi
authors: N
authors: Nagano
authors: Hitomi
authors: H
authors: Yamamoto
authors: Kazunori
authors: K
authors: Hyoma
authors: Sachiko
authors: S
authors: Yamada
authors: Hiroko
authors: H
authors: Hirano
authors: Yoshinori
authors: Y
authors: Tone
authors: Haruhisa
authors: H
authors: Ohtani
authors: Yasushi
authors: Y
authors: Saika
authors: Ryoichi
authors: R
authors: Fujii